General MedicationsORALGeneric
NORVIR
RITONAVIR
Standard Dose
80MG/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview NORVIR is listed in Drugs@FDA under application 020659 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient RITONAVIR Form and strength SOLUTION;ORAL - 80MG/ML Sponsor ABBVIE Submission history Latest submission status date: 2022-12-15 00:00:00.
Structured Monograph
Clinical summary
Approval overview NORVIR is listed in Drugs@FDA under application 020659 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient RITONAVIR Form and strength SOLUTION;ORAL - 80MG/ML Sponsor ABBVIE Submission history Latest submission status date: 2022-12-15 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.